Aligos Therapeutics (ALGS) Prepaid Assets (2019 - 2026)
Aligos Therapeutics (ALGS) reported Prepaid Assets of $4.5 million for Q1 2026, down 13.14% on a YoY basis from $5.2 million in Q1 2025, and down 7.38% quarter-over-quarter from $4.9 million in Q4 2025.
Aligos Therapeutics (ALGS) Prepaid Assets (2019 - 2026) Analysis & Trends
Aligos Therapeutics has reported Prepaid Assets for 8 years, with the latest figure at $4.5 million in Q1 2026.
- For the quarter ending Q1 2026, Prepaid Assets fell 13.14% year-over-year to $4.5 million; the trailing twelve-month figure through Mar 2026 stood at $4.5 million (down 13.14% YoY), and the FY2025 full-year result was $4.9 million, down 3.61% from the prior year.
- Prepaid Assets for Q1 2026 stood at $4.5 million, down from $4.9 million in the prior quarter.
- The five-year high for Prepaid Assets was $10.3 million in Q1 2022, with the low at $3.4 million in Q2 2023.
- Historically, Prepaid Assets has averaged $5.6 million across 5 years, with a median of $5.1 million in 2024.
- Annual changes were most pronounced in 2022 — Prepaid Assets surged 75.83% — and 2023, when it sank 59.58%.
- Aligos Therapeutics' Prepaid Assets stood at $7.6 million in 2022, then sank by 30.16% to $5.3 million in 2023, then declined by 4.11% to $5.1 million in 2024, then slipped by 3.61% to $4.9 million in 2025, then retreated by 7.38% to $4.5 million in 2026.
- The last three Prepaid Assets figures came in at $4.5 million (Q1 2026), $4.9 million (Q4 2025), and $4.2 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - |
| 10 | Aligos Therapeutics | 54.72 Mn | -25.11 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.55 Mn |
| Dec 31, 2025 | 4.91 Mn |
| Sep 30, 2025 | 4.23 Mn |
| Jun 30, 2025 | 4.89 Mn |
| Mar 31, 2025 | 5.23 Mn |
| Dec 31, 2024 | 5.09 Mn |
| Sep 30, 2024 | 4.79 Mn |
| Jun 30, 2024 | 4.96 Mn |
| Mar 31, 2024 | 5.11 Mn |
| Dec 31, 2023 | 5.31 Mn |
| Sep 30, 2023 | 4.14 Mn |
| Jun 30, 2023 | 3.36 Mn |
| Mar 31, 2023 | 5.52 Mn |
| Dec 31, 2022 | 7.60 Mn |
| Sep 30, 2022 | 7.71 Mn |
| Jun 30, 2022 | 8.32 Mn |
| Mar 31, 2022 | 10.30 Mn |
| Dec 31, 2021 | 13.53 Mn |
| Sep 30, 2021 | 5.83 Mn |
| Jun 30, 2021 | 5.80 Mn |